Becton Dickinson & Co
corporate_fare Company Profile
Becton Dickinson & Co (NYSE:BDX) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 26 items for BDX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-06, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 8 rated 8 or above. Recent SEC coverage for BDX spans 10-Q, 8-K, FWP, 8-K/A.
Recent high-impact activity:
- BD Q3 Revenue Up 5.4% but GAAP EPS Drops 34% on Higher Costs; Guidance Raised
- BD Q3 Profit Drops 34% to $377M, Misses Estimates; Guides FY EPS $12.62-$12.72
- BD Tops Q3 Forecasts and Lifts Full-Year EPS Guidance Midpoint
- BD Recalls Needle Sets After 4 Deaths, 45 Serious Injuries
- BD and EMS Launch Semaglutide GLP-1 Therapy in Brazil, Expanding Access
Financial Snapshot
Short Interest & Short Volume
7.19 days to coverFINRA reported short interest of 11,316,237 shares in BDX as of the September 15, 2026 settlement, a 6.0% increase from the prior period — about 7.2 days to cover at its recent average daily volume. On October 2, 2026, 50.0% of BDX volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for BDX, detected from its recent SEC filings · based on capital-structure filings through 2026-05-11.
Debt Offering Priced · Settlement Details
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →